These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32073004)

  • 1. The binding mode of vilazodone in the human serotonin transporter elucidated by ligand docking and molecular dynamics simulations.
    Zhang Y; Zheng G; Fu T; Hong J; Li F; Yao X; Xue W; Zhu F
    Phys Chem Chem Phys; 2020 Mar; 22(9):5132-5144. PubMed ID: 32073004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational identification of the binding mechanism of a triple reuptake inhibitor amitifadine for the treatment of major depressive disorder.
    Xue W; Wang P; Tu G; Yang F; Zheng G; Li X; Li X; Chen Y; Yao X; Zhu F
    Phys Chem Chem Phys; 2018 Feb; 20(9):6606-6616. PubMed ID: 29451287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbazole derivatives as promising competitive and allosteric inhibitors of human serotonin transporter: computational pharmacology.
    Ayipo YO; Ahmad I; Chong CF; Zainurin NA; Najib SY; Patel H; Mordi MN
    J Biomol Struct Dyn; 2024; 42(2):993-1014. PubMed ID: 37021485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antidepressant drug vilazodone is an allosteric inhibitor of the serotonin transporter.
    Plenge P; Yang D; Salomon K; Laursen L; Kalenderoglou IE; Newman AH; Gouaux E; Coleman JA; Loland CJ
    Nat Commun; 2021 Aug; 12(1):5063. PubMed ID: 34417466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The novel therapeutic strategy of vilazodone-donepezil chimeras as potent triple-target ligands for the potential treatment of Alzheimer's disease with comorbid depression.
    Li X; Li J; Huang Y; Gong Q; Fu Y; Xu Y; Huang J; You H; Zhang D; Zhang D; Mao F; Zhu J; Wang H; Zhang H; Li J
    Eur J Med Chem; 2022 Feb; 229():114045. PubMed ID: 34922191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A structural model of the human serotonin transporter in an outward-occluded state.
    Hellsberg E; Ecker GF; Stary-Weinzinger A; Forrest LR
    PLoS One; 2019; 14(6):e0217377. PubMed ID: 31251747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Y95 and E444 interaction required for high-affinity S-citalopram binding in the human serotonin transporter.
    Combs S; Kaufmann K; Field JR; Blakely RD; Meiler J
    ACS Chem Neurosci; 2011 Feb; 2(2):75-81. PubMed ID: 22778858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric Binding of MDMA to the Human Serotonin Transporter (hSERT) via Ensemble Binding Space Analysis with ΔG Calculations, Induced Fit Docking and Monte Carlo Simulations.
    Islas ÁA; Scior T
    Molecules; 2022 May; 27(9):. PubMed ID: 35566327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of the multimodal antidepressant drug vortioxetine to the human serotonin transporter.
    Andersen J; Ladefoged LK; Wang D; Kristensen TN; Bang-Andersen B; Kristensen AS; Schiøtt B; Strømgaard K
    ACS Chem Neurosci; 2015 Nov; 6(11):1892-900. PubMed ID: 26389667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Mechanism for the Allosteric Inhibition of the Human Serotonin Transporter by Antidepressant Escitalopram.
    Xue W; Fu T; Deng S; Yang F; Yang J; Zhu F
    ACS Chem Neurosci; 2022 Feb; 13(3):340-351. PubMed ID: 35041375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel serotonin reuptake inhibitors targeting central and allosteric binding sites: A virtual screening and molecular dynamics simulations study.
    Erol I; Aksoydan B; Kantarcioglu I; Salmas RE; Durdagi S
    J Mol Graph Model; 2017 Jun; 74():193-202. PubMed ID: 28499269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational characterization of the selective inhibition of human norepinephrine and serotonin transporters by an escitalopram scaffold.
    Zheng G; Yang F; Fu T; Tu G; Chen Y; Yao X; Xue W; Zhu F
    Phys Chem Chem Phys; 2018 Nov; 20(46):29513-29527. PubMed ID: 30457616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and inhibitory evaluation of 3-linked imipramines for the exploration of the S2 site of the human serotonin transporter.
    Brinkø A; Larsen MT; Koldsø H; Besenbacher L; Kolind A; Schiøtt B; Sinning S; Jensen HH
    Bioorg Med Chem; 2016 Jun; 24(12):2725-38. PubMed ID: 27160055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revealing vilazodone's binding mechanism underlying its partial agonism to the 5-HT
    Zheng G; Xue W; Yang F; Zhang Y; Chen Y; Yao X; Zhu F
    Phys Chem Chem Phys; 2017 Nov; 19(42):28885-28896. PubMed ID: 29057413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of antidepressants with the serotonin and norepinephrine transporters: mutational studies of the S1 substrate binding pocket.
    Sørensen L; Andersen J; Thomsen M; Hansen SM; Zhao X; Sandelin A; Strømgaard K; Kristensen AS
    J Biol Chem; 2012 Dec; 287(52):43694-707. PubMed ID: 23086945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural determinants of species-selective substrate recognition in human and Drosophila serotonin transporters revealed through computational docking studies.
    Kaufmann KW; Dawson ES; Henry LK; Field JR; Blakely RD; Meiler J
    Proteins; 2009 Feb; 74(3):630-42. PubMed ID: 18704946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetically encoded photocrosslinkers locate the high-affinity binding site of antidepressant drugs in the human serotonin transporter.
    Rannversson H; Andersen J; Sørensen L; Bang-Andersen B; Park M; Huber T; Sakmar TP; Strømgaard K
    Nat Commun; 2016 Apr; 7():11261. PubMed ID: 27089947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Location of the antidepressant binding site in the serotonin transporter: importance of Ser-438 in recognition of citalopram and tricyclic antidepressants.
    Andersen J; Taboureau O; Hansen KB; Olsen L; Egebjerg J; Strømgaard K; Kristensen AS
    J Biol Chem; 2009 Apr; 284(15):10276-84. PubMed ID: 19213730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steric hindrance mutagenesis in the conserved extracellular vestibule impedes allosteric binding of antidepressants to the serotonin transporter.
    Plenge P; Shi L; Beuming T; Te J; Newman AH; Weinstein H; Gether U; Loland CJ
    J Biol Chem; 2012 Nov; 287(47):39316-26. PubMed ID: 23007398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric Inhibition and Pharmacochaperoning of the Serotonin Transporter by the Antidepressant Drugs Trazodone and Nefazodone.
    El-Kasaby A; Boytsov D; Kasture A; Krumpl G; Hummel T; Freissmuth M; Sandtner W
    Mol Pharmacol; 2024 Jun; 106(1):56-70. PubMed ID: 38769018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.